AGT and pulmonary hypertension: With increased understanding of the hypoxia-induced pulmonary hypertension mechanisms, elevated endothelin (ET) and angiotensin II (Ang II) in combination with reduced bioavailability of the endogenous vasodilator nitric oxide (NO) have been documented [1–3].